SII Levels Following PENG Block in Hip Arthroplasty
ConditionHip Osteoarthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-100
SponsorPoznan University of Medical Sciences
About this trial
This randomized controlled trial evaluates the effect of ultrasound-guided Pericapsular Nerve Group (PENG) block on the Systemic Immune-Inflammation Index (SII) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SII, calculated as platelet × neutrophil / lymphocyte count, is used as a composite marker of perioperative inflammatory and immune response. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.
Eligibility criteria
Qualifiers
Patients with ASA classification I-III
Aged 65-100 years
Who will be scheduled for hip arthroplasty under spinal anesthesia
Disqualifiers
Patients who have a history of bleeding diathesis
Take anticoagulant therapy
History of chronic pain before surgery
Multiple trauma
Trial design
Treatments tested in this trial
- sodium Chloride
- Ropivacaine 0.2% Injectable Solution
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov